scholarly journals Profile of users of drugs for the treatment of chronic hepatitis B available through the Brazilian Public Health System

2012 ◽  
Vol 16 (4) ◽  
pp. 379-382 ◽  
Author(s):  
Astrid Wiens ◽  
Luana Lenzi ◽  
Mônica Cavichiolo Grochocki ◽  
Cassyano Januário Correr ◽  
Roberto Pontarolo
2016 ◽  
Vol 111 (4) ◽  
pp. 252-257 ◽  
Author(s):  
Camila V Pereira ◽  
Cristiane Valle Tovo ◽  
Thiago K Grossmann ◽  
Henrique Mirenda ◽  
Bruna B Dal-Pupo ◽  
...  

2019 ◽  
Vol 70 (1) ◽  
pp. e334-e335 ◽  
Author(s):  
Mei Lu ◽  
Yueren Zhou ◽  
Jia Li ◽  
Loralee B Rupp ◽  
Joseph A. Boscarino ◽  
...  

2018 ◽  
Vol 22 (4) ◽  
pp. 317-322 ◽  
Author(s):  
Iandra Holzmann ◽  
Cristiane V. Tovo ◽  
Roseline Minmé ◽  
Mônica P. Leal ◽  
Michele P. Kliemann ◽  
...  

Sexual Health ◽  
2012 ◽  
Vol 9 (2) ◽  
pp. 131 ◽  
Author(s):  
Jack Wallace ◽  
Stephen McNally ◽  
Jacqui Richmond ◽  
Behzad Hajarizadeh ◽  
Marian Pitts

Background The complexity of the hepatitis B natural history and its prevalence in specific populations in Australia challenges the capacity of the health system to deliver health care effectively to affected people. This study explores the challenges in delivering health care to people with chronic hepatitis B (CHB) in Australia. Methods: We conducted a grounded theory based qualitative study in which data were gathered from 70 in-depth interviews with government program officers, clinicians and health and community workers across Australia, and four focus group discussions with 40 health and community workers from the communities most at risk of CHB. Results: A systematic approach to screening populations at risk, including people born in countries with intermediate or high prevalence of CHB; consensus on clinical guidelines; development of a shared care framework for CHB involving general practitioners; and effective communication between patients and health professionals were identified as essential. Workforce development, particularly for primary health care professionals, and developing the knowledge and capacity of health professionals to communicate effectively with people with HBV were described as other major factors in reducing the barriers to CHB treatment in Australia. Conclusion: To improve the clinical management of people with CHB in Australia, the health system needs to encourage the screening of people at risk, improve access to clinical services, and the knowledge and communication skills of primary health care and community health service providers. This study supported developing a shared care model and related infrastructures including training programs, referral pathways and clinical guidelines.


Author(s):  
Eman Mohammad Al-Shawkany ◽  
Abdul-Al-Raoof Mohammad AlShawkany ◽  
Saleh S Bahaj ◽  
Arwa Mohammed Othman ◽  
Hassan A Al-Shamahy ◽  
...  

Background and aims: Hepatitis B virus infection is a significant public health crisis global. Hepatitis B virus genotyping is an important tool in epidemiological studies to determine the category and extent of treatment and to predict the outcome of chronic infections, for instance hepatocellular carcinoma and cirrhosis. The study designed to determine the prevalence of hepatitis B virus genotypes among Yemeni patients with chronic hepatitis B (CHB) and to evaluate some of the associated risk factors. Methods: Fifty patients (38 males, 12 females) with chronic hepatitis B from Al-Thawra Modern General Hospital, Al-Kuwait University Hospital, and AL-Gomhoria Hospital were included. HBV DNA was first detected by conventional PCR then HBV genotypes were determined using nested and multiplex PCR.  Results: Mixed HBV genotypes (A+B+C+D+E), (A+B+C+D+E+F), and  (A+B+C+D)  were found to be the most prevalent (60 %), it is followed by genotype D (16 %), genotype B (16%) and genotype A (8%), whereas C, E, and F genotype were not found individually among the study population. Blood transfusion was associated with mixed infection (χ2=13.06; p= 0.005). Conclusions: In assumption, this study demonstrates the general prevalence of hepatitis B virus genotypes among HBV-infected Yemeni hepatitis B patients who request medical consideration in a hospital. In mono-genotype HBV infection, genotype B and D were the most prevalent genotypes. In HBV mixed genotype infection, the A/B/C/D/E genotype was the most prevalent in the study area. In the future, based on genotype, clinical trials and treatment regimens must be individually assumed to efficiently manage chronic HBV infection. To this end, a prospective nationwide population study of HBV genotype spreading and clinical outcomes is suggested.                    Peer Review History: Received: 15 May 2021; Revised: 11 June; Accepted: 27 June, Available online: 15 July 2021 Academic Editor:  Ahmad Najib, Universitas Muslim Indonesia, Makassar, Indonesia, [email protected] UJPR follows the most transparent and toughest ‘Advanced OPEN peer review’ system. The identity of the authors and, reviewers will be known to each other. This transparent process will help to eradicate any possible malicious/purposeful interference by any person (publishing staff, reviewer, editor, author, etc) during peer review. As a result of this unique system, all reviewers will get their due recognition and respect, once their names are published in the papers. We expect that, by publishing peer review reports with published papers, will be helpful to many authors for drafting their article according to the specifications. Auhors will remove any error of their article and they will improve their article(s) according to the previous reports displayed with published article(s). The main purpose of it is ‘to improve the quality of a candidate manuscript’. Our reviewers check the ‘strength and weakness of a manuscript honestly’. There will increase in the perfection, and transparency.  Received file:                Reviewer's Comments: Average Peer review marks at initial stage: 6.5/10 Average Peer review marks at publication stage: 7.5/10 Reviewer(s) detail: Dr. Salfarina Ramli,  Department of Pharmacology and Pharmaceutical Chemistry, Faculty of Pharmacy, Universiti Teknologi MARA, 42300 Puncak Alam, Selangor, Malaysia. [email protected]   Dr. Asia Selman Abdullah, University of Basrah, Iraq, [email protected] Similar Articles: EXPLOSION OF HEPATITIS B AND C VIRUSES AMONG HEMODIALYSIS PATIENTS AS A RESULT OF HEMODIALYSIS CRISIS IN YEMEN PREVALENCE AND GENOTYPING OF HEPATITIS C VIRUS IN HEMODIALYSIS PATIENTS AND EVALUATION OF HCV-CORE ANTIGEN TEST IN SCREENING PATIENTS FOR DIALYSIS IN SANA'A CITY, YEMEN PREVALENCE OF HBV AND HCV; AND THEIR ASSOCIATED RISK FACTORS AMONG PUBLIC HEALTH CENTER CLEANERS AT SELECTED PUBLIC HEALTH CENTERS IN SANA'A CITY-YEMEN


Sign in / Sign up

Export Citation Format

Share Document